Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi's sarcoma 19 and is associated with two B cell malignancies, primary effusion lymphoma and the 20 plasmablastic variant of multicentric Castleman's disease. EphA2 functions as a cellular 21 receptor for the gH/gL glycoprotein complex of KSHV for several adherent cell types. KSHV 22
gH/gL was previously shown to also weakly interact with other members of the Eph family of 23 receptors. Whether these interactions are of functional consequence remained unclear so 24 far, even if other A-type Ephs were shown to be able to compensate for absence of EphA2 in 25 overexpression systems. Here, we demonstrate for the first time that endogenously 26 expressed EphA7 in BJAB B cells is critical for the cell-to-cell transmission of KSHV from 27 producer iSLK cells to BJAB target cells. The BJAB lymphoblastoid cell line often serves as a 28 model for B cell infection and expresses only low levels of all Eph family receptors other than 29
EphA7. Endogenous EphA7 could be precipitated from the cellular lysate of BJAB cells using 30 recombinant gH/gL, and knockout of EphA7 significantly reduced transmission of KSHV into 31 BJAB target cells by over 80%. Finally, we demonstrate that receptor function of EphA7 is 32 conserved between cell-to-cell transmission of KSHV and cell-free infection by the related 33 rhesus monkey rhadinovirus (RRV), which is relatively even more dependent on EphA7 for 34 infection of BJAB cells. 35 36 IMPORTANCE 37
Infection of B cells is biologically relevant for two KSHV-associated malignancies, the 38 plasmablastic variant of multicentric Castleman's disease (MCD) and primary effusion 39 lymphoma (PEL). Elucidating the process of B cell infection is therefore important to 40 understand the pathogenesis of these diseases. For various types of adherent cells, EphA2 41 has been shown by several groups to function as an entry receptor that is engaged by the 42 gH/gL glycoprotein complex. Our previous findings indicate that KSHV does not only interact 43 with EphA2, but can also bind to other members of the Eph family of receptor tyrosine 44 kinases with comparatively lower avidity. We now analyzed the requirement of Eph 45 interactions for infection of the BJAB B cell line, a model for infection of B cells by KSHV. We 46 identify EphA7 as the principal Eph receptor for infection of this model B cell line by both 47 KSHV and the related rhesus monkey rhadinovirus. 48
INTRODUCTION 50
In addition to Kaposi's sarcoma, Kaposi's sarcoma-associated herpesvirus (KSHV) is 51 associated with a variant of multicentric Castleman's disease (MCD) and with primary 52 effusion lymphoma (PEL) (1) . Several publications demonstrate the importance of the 53 cellular receptor EphA2 for KSHV entry into various adherent target cells (2-5). While the 54 KSHV gH/gL complex exhibits the highest avidity for EphA2, it can also interact with other 55 members of the Eph family of receptor tyrosine kinases (Ephs), similar to the gH/gL complex 56 of the related rhesus monkey rhadinovirus (RRV) (6). However, so far it was unclear whether 57 these interactions are of functional relevance for KSHV infection at endogenous protein 58 levels. Interestingly, in vitro infection of established B cell lines by cell-free KSHV is extremely 59 inefficient (7), while coculture of KSHV producing cells with target cells leads to robust 60 infection (8). BJAB cells (9) are used as a model for B cell infection by KSHV (7, 8) and B cell 61 biology in general (10). Our previous work had already demonstrated that cell-to-cell 62 transmission of KSHV into BJAB cells is susceptible to inhibition of the interaction with 63 receptors from the Eph family (6) . An open question so far was which member of the Eph 64 family of receptor tyrosine kinases is the principal receptor for infection of these cells. 65
Additionally, we investigated the receptor requirements for BJAB infection by RRV, a closely 66 related gamma2-herpesvirus of rhesus macaques (11) to further characterize its significance 67 as an animal model virus for KSHV. 68
69

RESULTS
70
We performed a two-step pulldown from the lysate of BJAB cells using Strep-tagged Fc 71 fusion proteins of soluble versions of the gH proteins of KSHV, RRV 26-95 and RRV 17577 72 (12) in complex with the respective gL proteins as bait to identify cellular interaction 73 partners ( Figure 1A ). While our group works with RRV isolate 26-95, we included isolate 74 17577 to identify possible differences in receptor interactions between the two described 75 RRV isolates. Subsequent mass spectrometry analysis identified EphA7 as a prey in all three 76 binding reactions ( Figure 1B ). In pulldowns with both RRV gH/gL complexes, EphA7 was the 77 only membrane protein identified in excised bands in the 100-130kDa molecular weight 78 range. In the KSHV pulldown we additionally found several peptides derived from EphA5. A 79 comparison of the mRNA expression profiles of the 14 human Eph family receptors in a 80 dataset (13) deposited in the Gene Expression Omnibus database revealed that BJAB cells 81 predominantly express EphA7 ( Figure 1C ). We therefore focused our analysis on this 82 member of the Eph receptor family. To confirm our mass spectrometry results, we repeated 83 the pulldown with a similar experimental protocol and tested the precipitate for the 84 presence of EphA7 by Western blot analysis. We could confirm that using soluble gH/gL 85 complexes of KSHV and RRV 26-95 we pulled down a protein that reacted with an antibody 86 to EphA7 from BJAB lysate, but not from 293T lysate ( Figure 1D ). In contrast, EphA2 was 87 precipitated by KSHV gH/gL from 293T lysate but not from BJAB lysate, which mirrors 88 expression of the two receptors in BJAB or 293T, respectively ( Figure 1E ). To test the 89 functional relevance of the gH/gL-EphA7 interaction, we generated EPHA7 knockout (KO) 90 cell pools by transducing BJAB with lentiCRISPRv2-based constructs targeting EPHA7. All four 91 tested single guide RNAs (sgRNA) abrogated EphA7 expression compared to two non-92 targeting guide RNAs or two guide RNAs targeting EPHA2 as assayed by Western blot ( Figure  93 2A). EphA2, the described KSHV receptor for adherent cells, is not expressed to detectable 94 levels in BJAB cells ( Figure 1E , 2B). The weak signal detected by the polyclonal EphA2 95 antibody in BJAB lysates appears at an apparent molecular weight below that of EphA2 in 96 293T cell lysate and is therefore most likely a non-specific reactivity, which would also be in 97 accordance with mRNA expression profiles in databases and the absence of EphA2 in our 98 initial pulldown experiment. After confirmation of the CRISPR/Cas9 knockout efficiency, we 99 used the knockout cell pools to analyze receptor function of EphA7 for infection of BJAB 100 cells. As BJAB cells are not readily amenable to infection with cell-free KSHV, we resorted to 101 the previously described coculture cell-to-cell transmission system. This method allows for 102 efficient infection of BJAB cells by overlaying chemically induced iSLK cells with BJAB cells 103 and resolution of the two populations by flow cytometry after staining for expression of 104 CD13 (as iSLK cell marker) and CD20 (as B cell marker) as described by Myoung et al. (8) . In 105 addition to iSLK cells harboring BAC16 KSHV wt we included iSLK cells harboring our 106 previously described Eph-detargeted gH-ELAAN mutant in BJAB coculture experiments 107 ( Figure 2C ) (14). When the results obtained with all sgRNA constructs targeting one specific 108 gene were averaged (two non-targeting sgRNAs, two sgRNAs to EPHA2, four sgRNAS to 109 EPHA7), knockout of EPHA7 resulted in a 86% reduction of infection with wt KSHV, whereas 110 targeting EPHA2, which is not expressed at detectable levels as assayed by Western blot, 111 resulted in a 27% reduction of wt KSHV infection, which was not significant. Analysis of all 112 BJAB EPHA2 KO or EPHA7 KO cell pools compared to control cell pools in infection experiments 113 with KSHV gH-ELAAN did not indicate significant changes between any of the groups. RRV 114 26-95, as opposed to KSHV, readily infects BJAB cells as free virus. Therefore, we infected 115 the same set of knockout BJAB cells with cell-free wt RRV-YFP and with RRV-YFP gH-AELAAN, 116
an Eph-detargeted RRV mutant, analogous to KSHV gH-ELAAN ( Figure 2D ). While the results 117 obtained with RRV essentially paralleled those with KSHV, ablating EphA7 expression 118 resulted in an even more pronounced and significant reduction in infection for all EPHA7-119 targeting constructs when compared to the non-targeting controls. When averaged, the 120 BJAB EPHA7 KO cell pools exhibited a 95% reduction in RRV-YFP infection vs non-targeting 121 controls. Infection levels of RRV-YFP gH-AELAAN equaled RRV wt infection with matched 122 genome copy numbers on BJAB EPHA7 KO cells, with no significant differences between 123 controls and EPHA2 KO or EPHA7 KO cells. 124
As we still detected residual infectivity upon EPHA7 knockout, we wanted to address the 125 question, whether infection of EPHA7 KO BJAB cells could be further inhibited by a treatment 126 with ephrinA4-Fc, a soluble Fc-fusion protein of a natural Eph ligand, which targets A-type 127
Ephs and blocks infection of adherent cells by cell-free KSHV (6). This would indicate 128 receptor functions of additional A-type Eph proteins other than EphA7. To this end we used 129 a reduced set of our knockout cell pools and treated the cells either with PBS (control) or 130 ephrinA4-Fc in PBS during the coculture experiment ( Figure 3 ). While ephrin A4-Fc 131 significantly inhibited infection of both EPHA2 KO BJAB cells and non-targeting control BJAB 132 cells compared to PBS by over 85%, infection of EPHA7 KO BJAB cells was only reduced by 20% 133 in the presence of ephrinA4-Fc, which did not reach significance. It should be noted that 134 knockout of EPHA2 also lead to a small but significant reduction in infection in this 135 experiment using only a reduced set of sgRNA constructs. 136 137 DISCUSSION 138
We identified endogenous EphA7 in BJAB cell lysate as an interaction partner for the gH/gL 139 complexes of both KSHV and RRV. This is not surprising insofar that it had already been 140 shown in our previous publication that RRV binds relatively promiscuously to different Ephs, 141
and that KSHV binds EphA2 with high affinity, but can also interact with other Ephs, among 142 them EphA7, with lower affinity. We had also identified trace peptides of other Ephs 143 alongside peptides of EphA2 after pulldown with KSHV gH/gL previously. Additionally, we 144 had already identified EphA7 as an interaction partner for gH/gL of both RRV subtypes in 145
293T cells in a previous study (6) . In contrast, we were not able to precipitate endogenous 146
EphA7 from 293T cells with KSHV gH/gL under similar conditions, as was the case in previous 147 studies. The reason for the lack of EphA7 -gH/gL interaction in 293T cells is most likely 148 either competition by e.g. EphA2 for binding to the KSHV gH/gL complex and/or differences 149 in relative expression of the different Ephs ( Figure 1E ). While a recent publication by TerBush 150 et al.
(2) has already suggested that Ephs other than EphA2 can function as receptors for 151 KSHV, this has not been conclusively shown, as in this publication knockout of EPHA4 or 152 EPHA5 e.g. in SLK cell did not lead to a reduction in KSHV infection. Quite to the contrary, 153 EPHA4 knockout lead to an increase in infection. Demonstrating receptor function by a loss-154 of-function experiment such as gene knockout and not only after recombinant 155 overexpression is therefore essential to demonstrate biological relevance at endogenous 156 expression levels and in a physiological context. So far, only EphA2 has passed this test in 157 several publications (2-5). We now show that knockout of EPHA7 in BJAB cells resulted in a 158 receptor interactions in this context would not be informative. Nevertheless, we think that it 182 is highly likely that other Ephs, which like EphA5 weakly but detectably interact with KSHV 183 gH/gL (6), may play a role similar to EphA7 for KSHV infection of other cell types, in 184 particular in the absence of the high-affinity EphA2 receptor. This should be addressed in 185 separate studies using loss-of-function methodology. Overall, while KSHV exhibits the 186 highest affinity for EphA2, our results demonstrate that KSHV uses other Ephs under 187 circumstances where these are more abundantly expressed, which parallels the interaction 188 of ephrins with their receptors (15) and receptor usage by RRV (6). Whether there is a direct 189 correlation between affinity and receptor function or whether the mechanism is more 190 complicated will also be a subject for future studies. supplemented with 10% FBS and 50μg/ml gentamycin. iSLK cells were maintained in DMEM 208 supplemented with 10% FBS, 50μg/ml gentamycin, 2.5μg/ml puromycin (InvivoGen) and 209 250μg/ml G418 (Carl Roth). RRV-YFP, RRV-YFP gH-AELAAN and iSLK cells harboring BAC16 210 KSHV wt or BAC16 KSHV gH-ELAAN were produced as described previously (14). 211
Coculture infections. iSLK cells were seeded in 48well plates at 100 000 cells per well. After 212 five hours, lytic replication was induced with 1µg/ml doxycycline (Sigma) and 2.5mM sodium 213 butyrate (Carl Roth) over night in DMEM, high glucose, GlutaMAX, 25mM HEPES with 10% 214 FBS. After one day, medium was exchanged to 400µl RPMI with 10% FBS and 50µg/ml 215 gentamycin and the respective BJAB cell pools at 40 000 cells per well. For blocking 216 experiments, recombinant ephrinA4-Fc protein (R&D Systems) was added at the start of the 217 coculture to a final concentration of 2µg/ml. 218 Flow cytometry analysis. Cocultured cells were harvested by pipetting and fixed with 2% 219 formaldehyde (Carl Roth) in PBS. The cells were stained with anti-CD13 (clone WM15, PE 220 coupled, BIOLEGEND) and anti-CD20 (clone 2H7, Alexa647 coupled, BIOLEGEND) antibodies 221 at a 1:50 dilution in 5% FBS in PBS for 30min -45min. After 2 washes in PBS, the cells were 222 post-fixated in 2% formaldehyde in PBS. The samples were analyzed on a LSRII flow 223 cytometer (BD Biosciences). Flow cytometry data was further analyzed using Flowing 224 software (Version 2.5), for details see supplemental figure S1. Statistical analysis was carried 225 out using GraphPad Prism version 6 for Windows (GraphPad Software, La Jolla California 226 USA). 227
Generation of knockout cell pools. Knockout cell pools were generated using the 228 lentiCRISPRv2 system (18) as described previously (19), with the exception that transfection 229 was carried out using PEI (20). In short, BAJB cells were transduced with lentiviruses 230 harboring the indicated sgRNAs. After 48h the selection antibiotic puromycin (Invivogen) 231 was added to a final concentration of 10µg/ml. After initial selection the puromycin 232 concentration was reduced to 1µg/ml. The following single guide RNAs (sgRNAs) were 233 inserted into plentiCRISPRv2 (a kind gift from Feng Zhang (Addgene plasmid number 234 52961) Pulldown experiments and Western blot. Two-step pulldown with specific elution and re-244 precipitation using gH-FcStrep/gL complexes for identification by mass spectrometry was 245 performed as described previously (8) pre-coupled to Strep-Tactin XT (IBA) beads. After three washes with lysis buffer, the 255 precipitates were analyzed by polyacrylamide gel electrophoresis and Western blot as 256 described previously (14) using antibodies to and EphA2 (C-20, 257 sc-924), both from Santa Cruz Biotechnology, 1:100 and 1:500, respectively, in NET gelatine 258 (150mM NaCl, 5mM EDTA 50mM Tris, 0.05% Triton-X-100, 0.25% gelatin, pH 7.5) and 259 donkey anti-mouse HRP-coupled (Dianova) or goat anti-rabbit HRP coupled (Life 260 Technologies) secondary antibody in 5% dry milk powder in PBS with 0.05% Tween20. Suppl. Figure S1 . Gating strategy for scoring of KSHV infection in iSLK/BJAB cocultures. The 314 percentage of GFP + cells in the CD13 -CD20 + population is given for controls and one 315 representative iSLK BAC16 KSHV wt/BJAB control or iSLK BAC16 KSHV wt/BJAB EPHA7 KO 316 sample. Numbers in brackets represent event counts (CD13 -CD20 + GFP + events/ CD13 -317 CD20 + events). It should be noted that the 'iSLK BAC16 induced w/o BJAB' control sample, which 318 represents the assay background from e.g. spill-over, contained one CD13 -CD20 + GFP + 'false 319 positive' background event in 10 000 total events. This represents no more than 1.54% of 320 the CD13 -CD20 + GFP + population in any sample. 321 322 323 BIBLIOGRAPHY 324
